Login / Signup

Mobilizing China and the Global Community to Confront the Treatment Desert for Pediatric Solid Tumors.

Shuhang WangYale JiangRongshou ZhengYue YuWen-Qiang WeiNing Li
Published in: Cancer discovery (2024)
Pediatric solid tumors are distinct clinical entities that impose heavy socioeconomic burden and while their incidence has increased in recent years, treatment options are often limited, with only 27 drugs approved for pediatric solid tumors in the United States, and fewer still, 13, in China. The scale of the unmet medical need is immense and new efforts are urgently needed to develop efficient therapeutics and improve these children's lives.
Keyphrases
  • healthcare
  • risk factors
  • mental health
  • young adults
  • small molecule